Source: Biospectrum Asia

Kayentis: Kayentis raises $8.3M for its digital platform to expand clinical trials globally

Funds will strengthen Kayentis' digitalization approach in transforming how pharma, investigator sites and patients engage in clinical trials

Read full article »
Kayentis's Competitors | Kayentis's News | Kayentis's Financials
Stay up-to-date with the latest news on Kayentis
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Guillaume Juge's photo - President & CEO of Kayentis

President & CEO

Guillaume Juge

CEO Approval Rating

73/100

Read more
Stay up-to-date with the latest news on Kayentis